Safety Alerts Saves Lives
Safety Alerts  
Home Privacy About Us Contact Us Change Preferences

April 12, 2000

Eon Labs Manufacturing, Inc Recalls Isoxsuprine HCL Tablets

Laurelton, NY (SafetyAlerts) - The Food and Drug Administration (FDA) today reported that Eon Labs Manufacturing Inc is recalling Isoxsuprine HCL Tablets because of dissolution failure (42 month stability).

The recalled Isoxsuprine HCL Tablets, 10 mg and 20 mg, USP, in 100 and 1,000 tablet bottles, is a prescription indicated for the relief of symptoms associated with cerebral vascular insufficiency.  The recalled product was sold under the following labels:

NDC 0185-0530-01 (10 mg, bottles of 100s)
NDC 0185-0530-10 (10 mg, bottles of 1000s)
NDC 0185-0531-01 (20 mg, bottles of 100s)
NDC 0185-0531-10 (20 mg, bottles of 1000s)

NDC 0904-0635-60 (10 mg, bottles of 100s)
NDC 0904-0636-60 (20 mg, tablets of 100s)
NDC 0904-0636-80 (20 mg, bottles of 1000s).

According to the FDA, approximately 92,000 units were distributed nationwide. All lots within expiration date are affected by this recall.

This ongoing Class III recall was initiated by Eon Labs Manufacturing Inc., by letters dated November 19, 1999, January 12, 2000, and February 3, 2000.  This is the first public notice issued by the FDA.

Questions concerning this recall may be directed to the FDA at 1-888-INFO-FDA.
FDA Recall #d-259/260-0

Selected Recent Recalls

Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

Safety Alerts compiles comprehensive safety recall information for the United States. SafeMail is a free email service to warn consumers of faulty products and contaminated foods. For complete information regarding current recalls, past recalls and timely product warning notification visit:



The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.